Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(13%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_1
1
7%
Ph phase_3
1
7%
Ph phase_4
1
7%
Ph not_applicable
6
40%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(6)
Other(5)

Detailed Status

Completed6
unknown5
Enrolling by invitation2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A6 (66.7%)

Trials by Status

enrolling_by_invitation213%
recruiting213%
completed640%
unknown533%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials

All 15 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
15